CorFlow Therapeutics said yesterday that it won breakthrough device designation from the FDA for its Cofi device. Baar, Switzerland-based Corflow’s controlled flow infusion system is is designed to both assess coronary microcirculation after percutaneous coronary intervention procedures, including stenting, and to control the delivery of drugs to the smaller blood vessels not address by the […]
Search Results for: corflow
CorFlow raises $9.7 million to launch clinical trial in Europe
Swiss medical device developer CorFlow Therapeutics said today that it has raised $9.7 million in the second close of its seed+ financing round. The first round closed in October 2017 at $2.7 million (CHF 2.6 million). The proceeds will finance the first-in-man clinical trial in Europe of the company’s controlled flow infusion (CoFITM) system, which […]
CorFlow Therapeutics closes $3m seed round
Swiss medical device developer CorFlow Therapeutics said today it closed a $2.7 million (CHF 2.6 million) Seed+ round of financing to support a first-in-man trial of its platform designed to diagnose and treat microvascular obstructions. The round was led by private medical device investors and brings the total seed funding raised by the company up […]
